{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T08:51:33Z","timestamp":1781081493763,"version":"3.54.1"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2011,5,25]],"date-time":"2011-05-25T00:00:00Z","timestamp":1306281600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Hum Genet"],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1038\/ejhg.2011.89","type":"journal-article","created":{"date-parts":[[2011,5,25]],"date-time":"2011-05-25T10:16:38Z","timestamp":1306318598000},"page":"1059-1065","source":"Crossref","is-referenced-by-count":27,"title":["Treatment of spinal muscular atrophy cells with drugs that upregulate SMN expression reveals inter- and intra-patient variability"],"prefix":"10.1038","volume":"19","author":[{"given":"Eva","family":"Also-Rallo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Al\u00edas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebeca","family":"Mart\u00ednez-Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lidia","family":"Caselles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda J","family":"Barcel\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Montserrat","family":"Baiget","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Bernal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo F","family":"Tizzano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,5,25]]},"reference":[{"key":"BFejhg201189_CR1","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s00439-008-0598-1","volume":"125","author":"L Alias","year":"2009","unstructured":"Alias L, Bernal S, Fuentes-Prior P et al: Mutation update of spinal muscular atrophy in Spain: molecular characterization of 745 unrelated patients and identification of four novel mutations in the SMN1 gene. Hum Genet 2009; 125: 29\u201339.","journal-title":"Hum Genet"},{"key":"BFejhg201189_CR2","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/0092-8674(95)90460-3","volume":"80","author":"S Lefebvre","year":"1995","unstructured":"Lefebvre S, Burglen L, Reboullet S et al: Identification and characterization of a spinal muscular atrophy-determining gene. Cell 1995; 80: 155\u2013165.","journal-title":"Cell"},{"key":"BFejhg201189_CR3","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1038\/ng1195-335","volume":"11","author":"E Bussaglia","year":"1995","unstructured":"Bussaglia E, Clermont O, Tizzano E et al: A frame-shift deletion in the survival motor neuron gene in Spanish spinal muscular atrophy patients. Nat Genet 1995; 11: 335\u2013337.","journal-title":"Nat Genet"},{"key":"BFejhg201189_CR4","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1002\/humu.10245","volume":"22","author":"I Cusco","year":"2003","unstructured":"Cusco I, Lopez E, Soler-Botija C, Jesus Barcelo M, Baiget M, Tizzano EF : A genetic and phenotypic analysis in Spanish spinal muscular atrophy patients with c.399_402del AGAG, the most frequently found subtle mutation in the SMN1 gene. Hum Mutat 2003; 22: 136\u2013143.","journal-title":"Hum Mutat"},{"key":"BFejhg201189_CR5","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1007\/s00439-002-0681-y","volume":"110","author":"Y Martin","year":"2002","unstructured":"Martin Y, Valero A, del Castillo E, Pascual SI, Hernandez-Chico C : Genetic study of SMA patients without homozygous SMN1 deletions: identification of compound heterozygotes and characterisation of novel intragenic SMN1 mutations. Hum Genet 2002; 110: 257\u2013263.","journal-title":"Hum Genet"},{"key":"BFejhg201189_CR6","doi-asserted-by":"publisher","first-page":"6307","DOI":"10.1073\/pnas.96.11.6307","volume":"96","author":"CL Lorson","year":"1999","unstructured":"Lorson CL, Hahnen E, Androphy EJ, Wirth B : A single nucleotide in the SMN gene regulates splicing and is responsible for spinal muscular atrophy. Proc Natl Acad Sci USA 1999; 96: 6307\u20136311.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFejhg201189_CR7","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1093\/hmg\/8.7.1177","volume":"8","author":"UR Monani","year":"1999","unstructured":"Monani UR, Lorson CL, Parsons DW et al: A single nucleotide difference that alters splicing patterns distinguishes the SMA gene SMN1 from the copy gene SMN2. Hum Mol Genet 1999; 8: 1177\u20131183.","journal-title":"Hum Mol Genet"},{"key":"BFejhg201189_CR8","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1006\/bbrc.1995.2135","volume":"213","author":"M Gennarelli","year":"1995","unstructured":"Gennarelli M, Lucarelli M, Capon F et al: Survival motor neuron gene transcript analysis in muscles from spinal muscular atrophy patients. Biochem Biophys Res Commun 1995; 213: 342\u2013348.","journal-title":"Biochem Biophys Res Commun"},{"key":"BFejhg201189_CR9","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/S0014-5793(01)02330-4","volume":"495","author":"E Dodds","year":"2001","unstructured":"Dodds E, Dunckley MG, Roberts RG, Muntoni F, Shaw CE : Overexpressed human survival motor neurone isoforms, SMNDeltaexon7 and SMN+exon7, both form intranuclear gems but differ in cytoplasmic distribution. FEBS Lett 2001; 495: 31\u201338.","journal-title":"FEBS Lett"},{"key":"BFejhg201189_CR10","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1093\/hmg\/9.2.259","volume":"9","author":"CL Lorson","year":"2000","unstructured":"Lorson CL, Androphy EJ : An exonic enhancer is required for inclusion of an essential exon in the SMA-determining gene SMN. Hum Mol Genet 2000; 9: 259\u2013265.","journal-title":"Hum Mol Genet"},{"key":"BFejhg201189_CR11","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s00415-005-0912-y","volume":"253","author":"I Cusco","year":"2006","unstructured":"Cusco I, Barcelo MJ, Rojas-Garcia R et al: SMN2 copy number predicts acute or chronic spinal muscular atrophy but does not account for intrafamilial variability in siblings. J Neurol 2006; 253: 21\u201325.","journal-title":"J Neurol"},{"key":"BFejhg201189_CR12","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1086\/338627","volume":"70","author":"M Feldkotter","year":"2002","unstructured":"Feldkotter M, Schwarzer V, Wirth R, Wienker TF, Wirth B : Quantitative analyses of SMN1 and SMN2 based on real-time light cycler PCR: fast and highly reliable carrier testing and prediction of severity of spinal muscular atrophy. Am J Hum Genet 2002; 70: 358\u2013368.","journal-title":"Am J Hum Genet"},{"key":"BFejhg201189_CR13","doi-asserted-by":"publisher","first-page":"9808","DOI":"10.1073\/pnas.171105098","volume":"98","author":"JG Chang","year":"2001","unstructured":"Chang JG, Hsieh-Li HM, Jong YJ, Wang NM, Tsai CH, Li H : Treatment of spinal muscular atrophy by sodium butyrate. Proc Natl Acad Sci USA 2001; 98: 9808\u20139813.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFejhg201189_CR14","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1517\/13543784.11.12.1695","volume":"11","author":"WK Kelly","year":"2002","unstructured":"Kelly WK, O'Connor OA, Marks PA : Histone deacetylase inhibitors: from target to clinical trials. Expert Opin Investig Drugs 2002; 11: 1695\u20131713.","journal-title":"Expert Opin Investig Drugs"},{"key":"BFejhg201189_CR15","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/sj.ejhg.5201102","volume":"12","author":"C Andreassi","year":"2004","unstructured":"Andreassi C, Angelozzi C, Tiziano FD et al: Phenylbutyrate increases SMN expression in vitro: relevance for treatment of spinal muscular atrophy. Eur J Hum Genet 2004; 12: 59\u201365.","journal-title":"Eur J Hum Genet"},{"key":"BFejhg201189_CR16","doi-asserted-by":"publisher","first-page":"2481","DOI":"10.1093\/hmg\/ddg256","volume":"12","author":"L Brichta","year":"2003","unstructured":"Brichta L, Hofmann Y, Hahnen E et al: Valproic acid increases the SMN2 protein level: a well-known drug as a potential therapy for spinal muscular atrophy. Hum Mol Genet 2003; 12: 2481\u20132489.","journal-title":"Hum Mol Genet"},{"key":"BFejhg201189_CR17","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1002\/ana.10743","volume":"54","author":"CJ Sumner","year":"2003","unstructured":"Sumner CJ, Huynh TN, Markowitz JA et al: Valproic acid increases SMN levels in spinal muscular atrophy patient cells. Ann Neurol 2003; 54: 647\u2013654.","journal-title":"Ann Neurol"},{"key":"BFejhg201189_CR18","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1002\/ana.20548","volume":"58","author":"SM Grzeschik","year":"2005","unstructured":"Grzeschik SM, Ganta M, Prior TW, Heavlin WD, Wang CH : Hydroxyurea enhances SMN2 gene expression in spinal muscular atrophy cells. Ann Neurol 2005; 58: 194\u2013202.","journal-title":"Ann Neurol"},{"key":"BFejhg201189_CR19","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1038\/sj.ejhg.5201320","volume":"13","author":"C Brahe","year":"2005","unstructured":"Brahe C, Vitali T, Tiziano FD et al: Phenylbutyrate increases SMN gene expression in spinal muscular atrophy patients. Eur J Hum Genet 2005; 13: 256\u2013259.","journal-title":"Eur J Hum Genet"},{"key":"BFejhg201189_CR20","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1002\/ana.20836","volume":"59","author":"L Brichta","year":"2006","unstructured":"Brichta L, Holker I, Haug K, Klockgether T, Wirth B : In vivo activation of SMN in spinal muscular atrophy carriers and patients treated with valproate. Ann Neurol 2006; 59: 970\u2013975.","journal-title":"Ann Neurol"},{"key":"BFejhg201189_CR21","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.jns.2007.11.012","volume":"268","author":"WC Liang","year":"2008","unstructured":"Liang WC, Yuo CY, Chang JG et al: The effect of hydroxyurea in spinal muscular atrophy cells and patients. J Neurol Sci 2008; 268: 87\u201394.","journal-title":"J Neurol Sci"},{"key":"BFejhg201189_CR22","doi-asserted-by":"publisher","first-page":"e5268","DOI":"10.1371\/journal.pone.0005268","volume":"4","author":"KJ Swoboda","year":"2009","unstructured":"Swoboda KJ, Scott CB, Reyna SP et al: Phase II open label study of valproic acid in spinal muscular atrophy. PLoS One 2009; 4: e5268.","journal-title":"PLoS One"},{"key":"BFejhg201189_CR23","doi-asserted-by":"publisher","first-page":"2190","DOI":"10.1212\/WNL.0b013e3182020332","volume":"75","author":"TH Chen","year":"2010","unstructured":"Chen TH, Chang JG, Yang YH et al: Randomized, double-blind, placebo-controlled trial of hydroxyurea in spinal muscular atrophy. Neurology 2010; 75: 2190\u20132197.","journal-title":"Neurology"},{"key":"BFejhg201189_CR24","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/S0960-8966(06)80015-5","volume":"2","author":"TL Munsat","year":"1992","unstructured":"Munsat TL, Davies KE : International SMA consortium meeting. (26\u201328 June 1992, Bonn, Germany). Neuromuscul Disord 1992; 2: 423\u2013428.","journal-title":"Neuromuscul Disord"},{"key":"BFejhg201189_CR25","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1006\/geno.1996.0147","volume":"32","author":"L Burglen","year":"1996","unstructured":"Burglen L, Lefebvre S, Clermont O et al: Structure and organization of the human survival motor neurone (SMN) gene. Genomics 1996; 32: 479\u2013482.","journal-title":"Genomics"},{"key":"BFejhg201189_CR26","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1093\/jnen\/64.3.215","volume":"64","author":"C Soler-Botija","year":"2005","unstructured":"Soler-Botija C, Cusco I, Caselles L, Lopez E, Baiget M, Tizzano EF : Implication of fetal SMN2 expression in type I SMA pathogenesis: protection or pathological gain of function? J Neuropathol Exp Neurol 2005; 64: 215\u2013223.","journal-title":"J Neuropathol Exp Neurol"},{"key":"BFejhg201189_CR27","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/0162-3109(80)90052-1","volume":"2","author":"RI Mishell","year":"1980","unstructured":"Mishell RI, Shiigi JM, Mishell BB, Grabstein KH, Shiigi SM : Prevention of the immunosuppressive effects of glucocorticosteroids by cell-free factors from adjuvant-activated accessory cells. Immunopharmacology 1980; 2: 233\u2013245.","journal-title":"Immunopharmacology"},{"key":"BFejhg201189_CR28","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1212\/01.wnl.0000252934.70676.ab","volume":"68","author":"LR Simard","year":"2007","unstructured":"Simard LR, Belanger MC, Morissette S, Wride M, Prior TW, Swoboda KJ : Preclinical validation of a multiplex real-time assay to quantify SMN mRNA in patients with SMA. Neurology 2007; 68: 451\u2013456.","journal-title":"Neurology"},{"key":"BFejhg201189_CR29","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1093\/hmg\/6.8.1205","volume":"6","author":"DD Coovert","year":"1997","unstructured":"Coovert DD, Le TT, McAndrew PE et al: The survival motor neuron protein in spinal muscular atrophy. Hum Mol Genet 1997; 6: 1205\u20131214.","journal-title":"Hum Mol Genet"},{"key":"BFejhg201189_CR30","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/ng0797-265","volume":"16","author":"S Lefebvre","year":"1997","unstructured":"Lefebvre S, Burlet P, Liu Q et al: Correlation between severity and SMN protein level in spinal muscular atrophy. Nat Genet 1997; 16: 265\u2013269.","journal-title":"Nat Genet"},{"key":"BFejhg201189_CR31","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1038\/sj.ejhg.5200286","volume":"7","author":"AL Patrizi","year":"1999","unstructured":"Patrizi AL, Tiziano F, Zappata S, Donati MA, Neri G, Brahe C : SMN protein analysis in fibroblast, amniocyte and CVS cultures from spinal muscular atrophy patients and its relevance for diagnosis. Eur J Hum Genet 1999; 7: 301\u2013309.","journal-title":"Eur J Hum Genet"},{"key":"BFejhg201189_CR32","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1212\/01.wnl.0000201929.56928.13","volume":"66","author":"CJ Sumner","year":"2006","unstructured":"Sumner CJ, Kolb SJ, Harmison GG et al: SMN mRNA and protein levels in peripheral blood: biomarkers for SMA clinical trials. Neurology 2006; 66: 1067\u20131073.","journal-title":"Neurology"},{"key":"BFejhg201189_CR33","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s00439-003-1025-2","volume":"114","author":"C Helmken","year":"2003","unstructured":"Helmken C, Hofmann Y, Schoenen F et al: Evidence for a modifying pathway in SMA discordant families: reduced SMN level decreases the amount of its interacting partners and Htra2-beta1. Hum Genet 2003; 114: 11\u201321.","journal-title":"Hum Genet"},{"key":"BFejhg201189_CR34","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S1074-5521(02)00092-3","volume":"9","author":"CM Grozinger","year":"2002","unstructured":"Grozinger CM, Schreiber SL : Deacetylase enzymes: biological functions and the use of small-molecule inhibitors. Chem Biol 2002; 9: 3\u201316.","journal-title":"Chem Biol"},{"key":"BFejhg201189_CR35","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/S0092-8674(00)80211-1","volume":"89","author":"MJ Pazin","year":"1997","unstructured":"Pazin MJ, Kadonaga JT : What's up and down with histone deacetylation and transcription? Cell 1997; 89: 325\u2013328.","journal-title":"Cell"},{"key":"BFejhg201189_CR36","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1093\/hmg\/ddi130","volume":"14","author":"LE Kernochan","year":"2005","unstructured":"Kernochan LE, Russo ML, Woodling NS et al: The role of histone acetylation in SMN gene expression. Hum Mol Genet 2005; 14: 1171\u20131182.","journal-title":"Hum Mol Genet"},{"key":"BFejhg201189_CR37","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s10048-010-0268-z","volume":"12","author":"C Xu","year":"2011","unstructured":"Xu C, Chen X, Grzeschik S, Ganta M, Wang C : Hydroxyurea enhances SMN2 gene expression through nitric oxide release. Neurogenetics 2011; 12: 19\u201324.","journal-title":"Neurogenetics"},{"key":"BFejhg201189_CR38","first-page":"4334","volume":"6","author":"T Davis","year":"2000","unstructured":"Davis T, Kennedy C, Chiew YE, Clarke CL, deFazio A : Histone deacetylase inhibitors decrease proliferation and modulate cell cycle gene expression in normal mammary epithelial cells. Clin Cancer Res 2000; 6: 4334\u20134342.","journal-title":"Clin Cancer Res"},{"key":"BFejhg201189_CR39","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/S0022-3565(24)39156-6","volume":"294","author":"SA McGrath-Morrow","year":"2000","unstructured":"McGrath-Morrow SA, Stahl JL : G(1) Phase growth arrest and induction of p21(Waf1\/Cip1\/Sdi1) in IB3-1 cells treated with 4-sodium phenylbutyrate. J Pharmacol Exp Ther 2000; 294: 941\u2013947.","journal-title":"J Pharmacol Exp Ther"},{"key":"BFejhg201189_CR40","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1093\/toxsci\/kfp002","volume":"108","author":"M Jergil","year":"2009","unstructured":"Jergil M, Kultima K, Gustafson AL, Dencker L, Stigson M : Valproic acid-induced deregulation in vitro of genes associated in vivo with neural tube defects. Toxicol Sci 2009; 108: 132\u2013148.","journal-title":"Toxicol Sci"},{"key":"BFejhg201189_CR41","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.mrfmmm.2003.08.017","volume":"532","author":"EM Hammond","year":"2003","unstructured":"Hammond EM, Green SL, Giaccia AJ : Comparison of hypoxia-induced replication arrest with hydroxyurea and aphidicolin-induced arrest. Mutat Res 2003; 532: 205\u2013213.","journal-title":"Mutat Res"},{"key":"BFejhg201189_CR42","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1007\/s12325-008-0030-1","volume":"25","author":"D Dayangac-Erden","year":"2008","unstructured":"Dayangac-Erden D, Topaloglu H, Erdem-Yurter H : A preliminary report on spinal muscular atrophy lymphoblastoid cell lines: are they an appropriate tool for drug screening? Adv Ther 2008; 25: 274\u2013279.","journal-title":"Adv Ther"},{"key":"BFejhg201189_CR43","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1093\/hmg\/ddn357","volume":"18","author":"J Hauke","year":"2009","unstructured":"Hauke J, Riessland M, Lunke S et al: Survival motor neuron gene 2 silencing by DNA methylation correlates with spinal muscular atrophy disease severity and can be bypassed by histone deacetylase inhibition. Hum Mol Genet 2009; 18: 304\u2013317.","journal-title":"Hum Mol Genet"},{"key":"BFejhg201189_CR44","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1136\/jmg.2010.079004","volume":"47","author":"S Bernal","year":"2011","unstructured":"Bernal S, Alias L, Barcelo MJ et al: The c.859G>C variant in the SMN2 gene is associated with types II and III SMA and originates from a common ancestor. J Med Genet 2011; 47: 640\u2013642.","journal-title":"J Med Genet"},{"key":"BFejhg201189_CR45","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1212\/01.wnl.0000249142.82285.d6","volume":"68","author":"E Mercuri","year":"2007","unstructured":"Mercuri E, Bertini E, Messina S et al: Randomized, double-blind, placebo-controlled trial of phenylbutyrate in spinal muscular atrophy. Neurology 2007; 68: 51\u201355.","journal-title":"Neurology"},{"key":"BFejhg201189_CR46","doi-asserted-by":"publisher","first-page":"3645","DOI":"10.1093\/hmg\/ddp313","volume":"18","author":"L Garbes","year":"2009","unstructured":"Garbes L, Riessland M, Holker I et al: LBH589 induces up to 10-fold SMN protein levels by several independent mechanisms and is effective even in cells from SMA patients non-responsive to valproate. Hum Mol Genet 2009; 18: 3645\u20133658.","journal-title":"Hum Mol Genet"},{"key":"BFejhg201189_CR47","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1038\/ejhg.2009.116","volume":"18","author":"FD Tiziano","year":"2010","unstructured":"Tiziano FD, Pinto AM, Fiori S et al: SMN transcript levels in leukocytes of SMA patients determined by absolute real-time PCR. Eur J Hum Genet 2010; 18: 52\u201358.","journal-title":"Eur J Hum Genet"},{"key":"BFejhg201189_CR48","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1038\/nature07677","volume":"457","author":"AD Ebert","year":"2009","unstructured":"Ebert AD, Yu J, Rose Jr FF et al: Induced pluripotent stem cells from a spinal muscular atrophy patient. Nature 2009; 457: 277\u2013280.","journal-title":"Nature"}],"container-title":["European Journal of Human Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/ejhg201189.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ejhg201189","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ejhg201189.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T20:36:23Z","timestamp":1741206983000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ejhg201189"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5,25]]},"references-count":48,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["BFejhg201189"],"URL":"https:\/\/doi.org\/10.1038\/ejhg.2011.89","relation":{},"ISSN":["1018-4813","1476-5438"],"issn-type":[{"value":"1018-4813","type":"print"},{"value":"1476-5438","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,5,25]]}}}